Desferal Injection, Powder, For Solution
Product Images NDC 87081-467
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desferal (NDC 87081-467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mitem Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Desferal Pi Usa (Desferal Pi Usa)
This is a detailed excerpt from a pharmaceutical document that provides information on iron intoxication, chronic iron overload, dosage and administration guidelines, drug interactions, adverse reactions, contraindications, warnings, precautions, and dosage forms and strengths. The text covers aspects such as hypersensitivity reactions, auditory and ocular toxicity, renal toxicity, respiratory toxicity, growth suppression, infections, and cardiac dysfunction related to vitamin C use. It also mentions risks associated with Desferal treatment in patients with aluminum overload, along with patient counseling information and potential risks of embryo-fetal toxicity.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.